Market Analysis - Biobanking 2017
Biobank is a long-term storage and conservation facility for biological specimens, to support future scientific investigation. Biobanks consists of biomaterial resources such as cells, blood, tissues and serum which plays an important role in the scientific research, clinical trials and epidemiological reviews which contributed for a significant long time to a superior comprehension of specific infections, yet the staggeringly fast pace at which biotechnology, restorative research, and high amounts of phenotypic data which are continually added to every patient's case request that we make a stride back and take a gander at the master plan included. Regardless of the possibility that biobanks are viewed as a moderately new idea, the essential idea driving this extends additionally down in restorative history and begins in the steadily growing need to comprehend the clinical and epidemiological sides of various infections and the repercussions these angles would posture in further improvement of more productive approaches to cure and keep those sufferings.
The center standard behind the birth and development of biobanks is the need to by one means or another concentrate and encourage the stream of data required by a more perplexing methodology in today's examination which has outpaced the conventional theory driven principal structure that should be handled with a specific end goal to get fruitful structure from various perspectives. Therefore now days the worldwide biobanking business sector is seeking an exponential development owing to its growth. The Global biobank equipment and media market is expected to show a sharp ascent in rising economies because of extensive interest in this segment by the legislature and non-administrative associations. Universally, this market is driven by the expanding number of instances of interminable ailments, progresses in regenerative drugs, propels in biobanking, open mindfulness and government subsidizing. This market additionally confronts a few limitations and difficulties, for example, high cost systems, administrative issues, security issues and capacity issues. It has additionally brought up issues with respect to restorative and research morals. Institutionalizing conservation strategies and enhancing stockpiling and solidness conditions could add to the development of this market. Expanded support from the administration and open mindfulness could likewise fuel the development of this market.
Moreover, biobanks plays an essential part in the improvement of new medications which is further enlarging the market development. Various facilities such as hospitals, research laboratories, academic centers and commercial facilities collect biological specimens and biomaterials from biobanks. However, lack of high quality samples could pose a challenge to the growth of this industry. Global biobank market is categorized on the basis of disease based biobank, population biobanks and private sector biobank. Further, market is fragmented on the premise of utilization, for example, lung tumor, colorectal growth, cardiovascular ailment, breast cancer, immunology-immune system infections and central nervous system disorders.
The Worldwide biobanking market can be divided into two segments: Equipment and Consumables. This report covers the present scenario and the growth prospects of the Global Biobanking market for the period 2015-2019. Worldwide biobanking market size was esteemed at USD 142.million in 2011 and it is determined that this market will achieve USD 216.3 million in 2018 with the compound yearly development rate of 5.4 % from 2011 – 2018 and USD 2.61 billion in 2014 and is required to develop at a CAGR of 17.3% over the conjecture time frame. Rapidly, expanding medicinal services use is a central point anticipated that would help the biobanking market to showcase development over the figure time frame. Favorable government initiatives in the form of funds, contracts, grants, and other funding mechanisms have led to the growth in the R&D activities of the companies and various research organizations which in turn led to the development of novel bio-preservation services which is further expected to boost usage rates over the forecast period. This market witnessed an increased trend of mergers and acquisitions among sellers.
However, this market could also face challenges due to lack of standardized and quality biospecimens. The private sector biobanks market was USD.42.4.million in 2010 and it is projected that this market will reach market value of USD 93.7 million in 2018. The U.S and Europe have the largest market size in biobanks. However, the rapid growth in population in Asia Pacific countries will affect the market of the developed countries. Europe is the largest biorepositories market due to the huge demand from Netherlands, Italy, Germany U.K and several other countries.
Fig: Graph indicating exponential increase of Biobanking market
Topographically, the worldwide biobank equipment and media market is fragmented into North America (U.S.A. what's more, Canada), Europe (U.K., Germany, Italy, France, and Spain), Asia-Pacific (India, China, Australia, South Korea and Japan), Latin America, Middle East and Africa. For the most part North America commands the worldwide biobank equipment and media market which is trailed by Europe, Asia-Pacific and LAMEA. In 2014, North America was the key territorial market in worldwide bio preservation industry with an income share of more than 45% significantly because of novel medication advancements and treatments in biomedical research. Europe is additionally anticipated that would develop at a generous rate amid the estimate time frame as an outcome of quick development in the quantity of individuals experiencing life undermining infections. Rising government interests in the innovative work exercises is creating the requirement for bio-stockpiling, consequently boosting the bio-protection showcase in this area.
Fig: Graph indicating Geographical biobanking system
Asia-Pacific has a pioneering development in biobank market because of government activity and public awareness. However, Asian region is expected to emerge in the future because of nearness of vast populace base.
The biobanks market is commanded by some key merchants who represented more than 70% piece of the pie. These merchants incorporate Thermo Fischer Scientific Inc, New Brunswick Scientific Co. Inc., Beckman Coulter Inc and ,Tecan AG. Thermo Fisher is the world pioneer in the biobanking market giving more advantageous, cleaner and more secure answers for patients. There are some different names in this market also, for example, TAP Biosystems, NEXUS Biosystems, BioKryo GmbH and others.
Conferenceseries invites all the participants from all over the world to attend “3rd International Conference & Exhibition on Tissue Preservation and Biobanking” during August 23-24, 2017 in San Francisco, California, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.
Biobanking-2017 on behalf of its organizing Committee welcomes all the stem cell technologists, researchers, industrialists, young scientists as well as student and corporate delegates to participate and to have a great experience. The theme of the conference of Biobanking is based on “New Scientifical Innovations in Development of Tissue science and Biobanking Technologies”. During Biobanking conferences, the International symposiums, B2B meetings, international workshops will also be organized to discuss the specific topics in the field of Stem cell technology. The conference also welcomes International exhibitions form corporate sectors to showcase the recent advancements in the tools and techniques. The conference also welcomes International exhibitions form corporate sectors to showcase the recent advancements in tools and techniques.